RQM+
↗Monroeville, Pennsylvania, USA
RQM+ is the leading global MedTech-focused Contract Research Organization (CRO) and consulting firm. The company provides comprehensive, end-to-end support for medical device and in vitro diagnostic (IVD) manufacturers throughout the entire product lifecycle, from initial concept and clinical trials to regulatory approval and post-market surveillance.
Formed by the 2020 merger of Regulatory and Quality Solutions (R&Q) and Maetrics, RQM+ has rapidly expanded its global footprint and service offerings. The company integrates deep regulatory expertise with advanced technology solutions, such as its Fern.ai platform, to help clients navigate complex global requirements like the EU MDR and IVDR while accelerating time-to-market.
CLASSIFICATION
SIZE & FINANCIALS
Employees:501-1000
Revenue:$100M-$250M
Founded:2008
Ownership:private
Status:operating
FUNDING
Stage:Private Equity-Backed
Total Raised:$301M
Investors:Linden Capital Partners, SLR Capital Partners
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A - Service Provider
Modalities:Medical Devices, In Vitro Diagnostics (IVD), Software as a Medical Device (SaMD), Laboratory Services
Active Trials:1300
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Linden Capital Partners
Acquired By:Linden Capital Partners (Majority Stake) (2021-09-01)
Subsidiaries:Jordi Labs, Giotto Compliance, Libra Medical, CRO Kottmann
Key Partnerships:3Aware (Real-World Evidence solutions), DLA Piper (Legal/M&A support)
COMPETITION
Position:Leader
Competitors:NAMSA, MCRA, Veranex, ICON, ProPharma Group, Emergo by UL
LEADERSHIP
Key Executives:
John Potthoff - CEO
Julie Wnek - CFO
Ronnie Mahofski - EVP & General Manager, Consulting Services
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with RQM+. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.